Company Profile

Lipella Pharmaceuticals Inc
Profile last edited on: 6/9/2024      CAGE: 480R9      UEI: JBVNWFNEEV59

Business Identifier: Supportive care to cancer survivors with hemorrhagic cystitis
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

7800 Susquehanna Street Suite 505
Pittsburgh, PA 15208
   (412) 894-1853
Location: Single
Congr. District: 12
County: Allegheny

Public Profile

Lipella Pharmaceuticals Inc is a biotechnology company organized around offering supportive care to cancer survivors who develop hemorrhagic cystitis, as well as improved surveillance and imaging of patients with a history of transitional cell carcinoma. Several of the firm's products are in clinical trials and available for licensing and/or co-development. Lipella maintains a manufacturing facility used for the development of liposomal formulations intended for intravesical delivery and for theproduction of the firm's clinical trial materials. Lipella also has in clinical-stage pharmaceutical assets in additional urinary bladder conditions, as well as urine-based diagnostics. In March 2019 the firm reported investigational new drug (IND) approval for a phase-2a, multi-center, double-blind, placebo-controlled clinical study measuring the safety and efficacy of LP-10 for cancer survivors with hemorrhagic cystitis resulting from pelvic radiation therapy and/or systemic chemotherapy.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Jonathan H Kaufman -- President and CEO

  David Chancellor -- Director of Marketing

  Michael Chancellor -- CMO

  Allison Douck -- Director of Finance

  Michele Gruber -- Director of Operations

  John Park -- Director Business Development

  Jeannine Ramsey -- Clinical Coordinator